| Date | Title | Description |
| 06.07.2016 | Proscia CEO: Digital pathology is at inflection point | West said the funding would be used to add staff across software development and sales and marketing, including a director of sales position. He said the team built Proscia’s storage and distribution infrastructure to house its image analys... |
| 23.06.2014 | Definiens Secures EURO 15M |
MUNICH, GERMANY, Definiens AG, which offers a unique approach to tissue diagnostics aimed at helping physicians improve treatment, said that it has closed a round of financing for EURO 15 million.
>> Click here for more funding dat... |
| 23.06.2014 | Definiens Closes €15M Financing | Definiens AG, a Munich, Germany-based provider of a tissue diagnostics platform aimed at helping physicians improve treatment, closed a €15m financing round.
The round was led by Wellington Partners and Gilde Healthcare with participation f... |
| 01.10.2012 | Definiens AG Raises 10M in Funding | Definiens AG, a Munich, Germany-based provider of image analysis technology for digital pathology, has raised €10m (approximately $12.8m) in funding.
The round was led by Gilde Healthcare Partners, with participation from existing investors... |
| 01.10.2012 | Gilde Healthcare III leads EUR 10 million private financing of Definiens AG | Munich, Germany – Definiens AG, the leader in Image Analysis for Digital Pathology, today announced that it has closed a private round of financing of €10 million. The financing was led by Gilde Healthcare Partners. Existing investors inclu... |
| 01.10.2012 | Definiens Secures 10M EUROS |
MUNICH, GERMANY, Leader in Image Analysis for Digital Pathology, today announced that it has closed a private round of financing of EURO10 million. The financing was led by new investor Gilde Healthcare Partners.
>> Click here for ... |
| - | Proscia CEO: Digital pathology is at inflection point | If you were looking for some major milestone events indicating the level of interest in digital pathology, you could focus on last week when Philips acquired tumor analysis business PathXL, based in Belfast, Northern Ireland. A couple of ye... |
